MIRA
INFORM REPORT
|
Report Date : |
07.11.2008 |
IDENTIFICATION
DETAILS
|
Name : |
BIOPHARM GROUP |
|
|
|
|
Registered Office : |
57 Corniche El
Nil, Maadi, Cairo 11431 |
|
|
|
|
Country : |
Egypt |
|
|
|
|
Financials (as on) : |
31.12.2007 |
|
|
|
|
Date of Incorporation : |
2000 |
|
|
|
|
Legal Form : |
Limited Liability Partnership |
|
|
|
|
Line of Business : |
Manufacture of Pharmaceuticals |
RATING &
COMMENTS
|
MIRA’s Rating : |
Ba |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
Maximum Credit Limit : |
US$ 250,000 |
|
|
|
|
Status : |
Satisfactory |
|
|
|
|
Payment Behaviour : |
No Complaints |
|
|
|
|
Litigation : |
Clear |
SUMMARY
Company Name : BIOPHARM GROUP
Country of Origin : Egypt
Legal Form : Limited Liability Partnership
Registration Date : 2000
Issued Capital : £E 64,000,000
Paid up Capital : £E 64,000,000
Total Workforce : 150
Activities : Manufacture of pharmaceuticals
Financial Condition : Fair
Payments : Nothing detrimental uncovered
Operating Trend : Steady
Recommended Credit Limit : US$ 250,000
Person Interviewed : Mahmoud Shaker, Export Manager
COMPANY NAME
BIOPHARM GROUP
ADDRESS
Registered & Physical Address
Street : 57 Corniche El Nil
Area : Maadi
Town : Cairo 11431
Country : Egypt
Telephone : (20-2) 25262300
Facsimile : (20-2) 25262300
Email : info@biopharmgroup.com
Premises
Subject operates
from a medium sized suite of offices that are rented and located in the Central
Business Area of Cairo.
Branch Office
(s)
Location Description
·
3rd
Industrial Zone, Plot No. 96 Owned
factory premises covering
Sixth of October City 100,000
square feet
Tel: (20-2) 38302727
Fax: (20-2) 38302839
KEY PRINCIPALS
Name Position
·
Dr
Osama Kandeel Managing
Partner
·
Mahmoud
Saqr Partner
·
Dr
Mamdouh Mostafa Factory
Manager
·
Mahmoud
Shaker Export
Manager
·
Tariq
Saleh Finance
Manager
LEGAL FORM & OWNERS
Date of Establishment : 2000
Legal Form :
Limited Liability
Partnership
Issued Capital : £E 64,000,000
Paid up Capital : £E 64,000,000
Name of Shareholder (s)
·
Dr
Osama Kandeel
·
Mahmoud
Saqr
OPERATIONS
Activities: Engaged in the manufacture of
pharmaceuticals specialising in medicines from natural products.
Import
Countries: United States of
America and India
Operating Trend: Steady
Subject has a
workforce of approximately 150 employees.
FINANCIAL DATA
Financial
highlights provided by local sources are given below:
Currency: Egyptian
Pounds (£E)
Year
Ending 31/12/06: Year
Ending 31/12/07:
Total Sales £E 18,200,000 £E 20,750,000
Local sources
consider subject’s financial condition to be Fair.
BANKERS
·
National
Societe General Bank
1 El Mahatta Square
Maadi
Cairo
Tel: (20-2) 27680025
PAYMENT HISTORY
No complaints
regarding subject’s payments have been reported.
GENERAL COMMENTS
During the course
of this investigation nothing detrimental was uncovered regarding subject’s
operating history or the manner in which payments are fulfilled. As such the
company is considered to be a fair trade risk and the above credit figure is
within subject’s financial means.
FOREIGN EXCHANGE
RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.47.76 |
|
UK Pound |
1 |
Rs.74.87 |
|
Euro |
1 |
Rs.60.81 |
RATING
EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit transaction.
It has above average (strong) capability for payment of interest and
principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General unfavourable
factors will not cause fatal effect. Satisfactory capability for payment of
interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Unfavourable & favourable factors carry similar weight in credit
consideration. Capability to overcome financial difficulties seems
comparatively below average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
NR |
In view of the lack of information, we have no basis upon which to
recommend credit dealings |
No Rating |
|
This score serves as a reference to assess SC’s credit risk
and to set the amount of credit to be extended. It is calculated from a composite
of weighted scores obtained from each of the major sections of this report. The
assessed factors and their relative weights (as indicated through %) are as
follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)